Anjali Jain

Also affiliated with Hospital for Sick Children, CT Group Of Institutions, Bristol-Myers Squibb (Belgium)

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn’s disease”.

Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn’s disease

Therapeutic Advances in Gastroenterology(2020)10.1177/1756284820971214

N/A

0DataRank · unranked

17 citations

Robert Battat, Parambir S. Dulai, Niels Vande Casteele, Nghia Nguyen, Anjali Jain +8 more

Patients With Low Drug Levels or Antibodies to a Prior Anti–Tumor Necrosis Factor Are More Likely to Develop Antibodies to a Subsequent Anti–Tumor Necrosis Factor

Clinical Gastroenterology and Hepatology(2021)10.1016/j.cgh.2021.01.006

N/A

0DataRank · unranked

29 citations

María T. Abreu, Sarah N. Flier, Konstantinos Papamichael, Florian Rieder, Mark S. Silverberg +6 more

Impact of Thiopurine Exposure on Immunogenicity to Infliximab Is Negligible in the Setting of Elevated Infliximab Concentrations

Inflammatory Bowel Diseases(2021)10.1093/ibd/izab232

N/A

0DataRank · unranked

15 citations

Jean‐Frédéric Colombel, Marla C. Dubinsky, Anjali Jain, Thierry Dervieux, Ryan C. Ungaro